Navigation Links
Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
Date:4/24/2008

138.8

Income from Discontinued Operations

(net of income tax provision of $0.1

in 2007) - 0.1

Loss on Disposal of Discontinued

Operations (0.4) -

Net Income $233.0 9.1% $138.9 5.9%

Earnings per Share from Continuing

Operations:

Basic $.56 $.33

Diluted $.54 $.31

Earnings per Share:

Basic $.56 $.33

Diluted $.53 $.31

Weighted Average Shares:

Basic 417.5 420.1

Diluted 436.2 441.1

Reconciliation of Adjusted Operating

Income and Adjusted Operating Margin

GAAP Operating Income (a) $290.4 11.4% $192.4 8.2%

Cost of Revenues Charges (c) 0.6 0.0% 36.4 1.6%

Restructuring and Other Costs, Net (d) 4.9 0.2% 7.4 0.3%

Amortization of Acquisition-related

Intangible Assets 151.2 5.9% 139.3 6.0%

Adjusted Operating Income (b) $447.1 17.5% $375.5 16.1%

Reconciliation of Adjusted Net Income

GAAP Net Income (a) $233.0 9.1% $138.9 5.9%

Cost of Revenues Charges (c) 0.6 0.0% 36.4 1.6%

Restructuring and Other Costs, Net (d) 4.9 0.2% 7.4 0.3%

Amortization of Acquisition-related

Intangible Assets 151.2 5.9% 139.3 6.0%

Amortization of Acquisition-related

Intangible Assets - Equity Investments 0.7 0.0% - 0.0
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Thermo Fisher Scientific to Present at Upcoming Investor Conferences
2. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 24, 2008
3. Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008
4. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
5. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
6. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
7. Thermo Fisher Scientific to Webcast Press Conference at PITTCON 2008
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
11. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LifeCell Dx and its founder, Dr. Lani ... Advanced Semen Analysis before they do anything else about ... risk factors for struggling couples.Too often, the traditional path ... the infertility. Infertility is fairly equally divided between the ... least complicated and inexpensive analysis that provides far more ...
(Date:3/5/2015)... DIEGO and TORONTO , ... TSX: APS), a clinical-stage company developing new therapeutics and ... today announced that William G. Rice , Ph.D., ... the upcoming 27th Annual ROTH Conference on Tuesday, March ... The Ritz Carlton, Laguna Niguel, CA. ...
(Date:3/5/2015)... (UK) (PRWEB) March 05, 2015 The ... polymer have received the CE mark (European) approval. The ... European Free Trade Association (EFTA) and the European Union. ... has now been granted to implants supplied by the ... spinal conditions. , Osimplant's Cervical Expandable Bladed HA ...
(Date:3/4/2015)... BROOKLYN, N.Y. , March 4, 2015  Brooklyn ... treat their acute and chronic pain and injuries. ... to announce the grand opening of his NJS Physical ... NY on Thursday, March 5, 2015. Health ... the facility, which is located at 1178 Flatbush Avenue. ...
Breaking Biology Technology:LifeCell Dx Offers New Option to Veterans with Infertility 2LifeCell Dx Offers New Option to Veterans with Infertility 3Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2
... release of it,s advanced nutritional supplement, Caplex, ... unique patent pending formulation created by an ... cancer patients a comprehensive source of the most ... results accumulated from medical research. Impressive changes in ...
... of Standards and Technology (NIST) have demonstrated a new ... intersection while keeping their cool. Ten million times cooler ... described in a forthcoming paper in Physical Review ... technology to build a large-scale quantum computer using ions ...
... Sinobiopharma Pharmaceutical Group (OTC Bulletin Board: SNBP) ... Yan Tan as Director of Marketing.Ms. Tan joins ... served as a China-based Unit Marketing Director for ... to Organon, Ms. Tan held senior marketing management ...
Cached Biology Technology:Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option 2X marks the spot: Ions coldly go through NIST trap junction 2Sinobiopharma, Inc. Appoints New Director of Marketing 2
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... NEW YORK (DECEMBER 30, 2008)The Bronx Zoo-based Wildlife Conservation Society ... region in South America have paid off in the form ... by the Government of Argentina. ... which became official earlier this month, protects half a million ...
... E or a combination of the supplements had a similar ... supplements, according to data from a randomized controlled trial in ... the National Cancer Institute. Epidemiological studies have suggested ... and thus antioxidants, may have a lower risk of cancer. ...
... COLUMBUS, Ohio Researchers at The Ohio State University ... in leukemia and lung cancer is also important in ... mainly children. The study shows that immature ... mature, and that the molecule is nearly missing in ...
Cached Biology News:A happy new year for penguins 2Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial 2Study links molecule to muscle maturation, muscle cancer 2
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
The SmartSpec printer paper is used to record data generated by the SmartSpec Plus spectrophotometer. Supplied as 5 packs....
The thermal printer, 120 V, is used to record fluorescence data acquired with the VersaFluor fluorometry systems. The printer includes a cable and power adaptor....
The Econo gradient pump rack is a preassembled rack that is used to hold the components of the Econo gradient pump kits....
Biology Products: